Beta Bionics, Inc. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-07-29: Form 10-Q; Exhibit 10.2; Description Amendment No. 3 to Development and Commercialization Agreement, dated July 8, 2026 by and between Abbott Diabetes Care, Inc. and the Registrant..
- 2026-07-29: Form 10-Q; Exhibit 10.1; Description Amendment No. 2 to Development and Commercialization Agreement, dated December 5, 2025 by and between Abbott Diabetes Care, Inc. and the Registrant..
- 2026-02-24: Form 10-K; Exhibit 10.10; Description Non-Employee Director Compensation Policy..
- 2025-07-29: Form 10-Q; Exhibit 10.1; Description Amendment No. 1 to Development and Commercialization Agreement, dated May 9, 2025, by and between Abbott Diabetes Care Inc. and the Registrant..
| Filed | Form | Exhibit | Description |
|---|
| 2026-07-29 | 10-Q | 10.2 | Amendment No. 3 to Development and Commercialization Agreement, dated July 8, 2026 by and between Abbott Diabetes Care, Inc. and the Registrant. |
|---|
| 2026-07-29 | 10-Q | 10.1 | Amendment No. 2 to Development and Commercialization Agreement, dated December 5, 2025 by and between Abbott Diabetes Care, Inc. and the Registrant. |
|---|
| 2026-02-24 | 10-K | 10.10 | Non-Employee Director Compensation Policy. |
|---|
| 2025-07-29 | 10-Q | 10.1 | Amendment No. 1 to Development and Commercialization Agreement, dated May 9, 2025, by and between Abbott Diabetes Care Inc. and the Registrant. |
|---|